Stuart J. Pocock
Statistics and Probability · 2000–2021
A researcher in the Science corpus: 40 papers; trusts 12 researchers and is trusted by 24 researchers here, as inferred from the citation graph.
Subfields
- Statistics and Probability — 126 citations into it; #1,961 of 12,932 by trust here, #122 by citations
- Economics and Econometrics — 69 citations into it; #5,046 of 23,481 by trust here, #667 by citations
- Public Health, Environmental and Occupational Health — 36 citations into it
- General Health Professions — 32 citations into it; #1,733 of 4,781 by trust here, #142 by citations
- Sociology and Political Science — 17 citations into it; #11,769 of 22,756 by trust here, #1,401 by citations
- Oncology — 8 citations into it
Whom Stuart J. Pocock trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- David Moher
- Douglas G. Altman
- K. F. Schulz
- John P. A. Ioannidis
- Peter Jüni
- Ian R. White
- S. Senn
- Patrick Royston
- Matthias Egger
- Diana Elbourne
Who trusts Stuart J. Pocock overall
- Douglas G. Altman
- K. F. Schulz
- Kosuke Imai
- David Moher
- Jared C. Foster
- Jan Derks
- Guha Balakrishnan
- Gary S. Collins
- James Jordon
- S. Cuschieri
Papers from Stuart J. Pocock's perspective
Ordered by how strongly the researchers Stuart J. Pocock trusts endorse each paper. Same corpus, a different order for every researcher.
- CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (British medical journal)
- Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review (Medical Journal of Australia)
- External validity of randomised controlled trials: "to whom do the results of this trial apply?".
- Evidence b(i)ased medicine—selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications (British medical journal)
- Multiple imputation using chained equations: Issues and guidance for practice (Statistics in Medicine)
- Non‐inferiority trials: design concepts and issues – the encounters of academic consultants in statistics (Statistics in Medicine)
- WHO antenatal care randomised trial for the evaluation of a new model of routine antenatal care. (The Lancet)
- Dichotomizing continuous predictors in multiple regression: a bad idea (Statistics in Medicine)
- Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls (British medical journal)
- [The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies]. (Revista Española de Salud Pública)
Their papers
- Subgroup analysis and other (mis)uses of baseline data in clinical trials. (2000) — 1,218 citations
- Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practiceand problems (2002) — 1,118 citations
- Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies (2007) — 44,764 citations
- Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. (2006) — 997 citations
- Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. (2006) — 1,902 citations
- Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration (2007) — 9,533 citations
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies (2007) — 4,803 citations
- Strategy for intention to treat analysis in randomised trials with missing outcome data (2011) — 818 citations
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. (2007) — 9,582 citations
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. (2007) — 6,189 citations
- Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. (2007) — 2,675 citations
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies (2007) — 11,147 citations
- Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. (2009) — 1,355 citations
- Adaptive increase in sample size when interim results are promising: A practical guide with examples (2011) — 348 citations
- Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis. (2007) — 804 citations
- Empagliflozin in Heart Failure with a Preserved Ejection Fraction. (2021) — 3,081 citations
- SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials. (2020) — 1,064 citations
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure (2020) — 3,699 citations
- Ticagrelor with or without Aspirin in High-Risk Patients after PCI. (2019) — 811 citations
- Transcatheter Aortic‐Valve Replacement with a Balloon‐Expandable Valve in Low‐Risk Patients (2019) — 3,684 citations